ArticleOxford open immunology2026
Structural homology of HHV-6B epitopes as candidates for molecular mimicry triggers of the onset type one diabetes mellitus.
Article in Oxford open immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To study whether HHV-6B can act as a molecular mimic to trigger onset of Type One Diabetes Mellitus (T1DM) by assessing structural and binding similarities between HHV-6B derived epitopes and T1DM autoantigen derived epitopes. Methods: Epitope peptide structures and their interactions with T1DM autoantigens were modeled using Boltz-2, a state-of-the-art artificial intelligence protein structure prediction method. Results: Several HHV-6B epitopes studied here demonstrated high structural alignment with T1DM antigen epitopes, but even when structural homology was lacking, in multiple cases the HHV-6B and T1DM epitopes fit into the same binding region of the corresponding HLA molecules, suggesting a plausible structural basis for T cell cross-reactivity. These findings support the hypothesis that HHV-6B may act as a molecular mimic contributing to autoimmune responses in individuals genetically susceptible to T1DM. Conclusion: This study demonstrates that structural modeling is a useful tool for identifying potential mimicry candidates that sequence-based methods may not find, underscoring the importance of integrating structure-based modeling, including docking, into molecular mimicry prediction pipelines for identifying potential epitopes for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.